Patent and Regulatory Landscape of Biosimilars in the United States and Europe: Implications for Advancing the Domestic Biosimilar Industry with a Focus on Anti-TNF-α Biopharmaceuticals
Biopharmaceuticals exhibit excellent therapeutic efficacy; however, their high cost remains a significant limitation. The introduction of biosimilars is expected to enhance market competition and reduce biopharmaceutical prices. As of January 2025, Europe has approved 92 biosimilars for 25 reference...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korea Institute of Intellectual Property
2025-06-01
|
| Series: | Journal of Intellectual Property |
| Subjects: | |
| Online Access: | https://jip.or.kr/2002-01/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|